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Metastatic renal cell carcinoma to pancreas 
and gastrointestinal tract: a clinicopathological 
study of 3 cases and review of literature
Jamshid Abdul‑Ghafar1* , Nasir Ud Din2, Ramin Saadaat1 and Zubair Ahmad2 
Abstract 
Background: Renal Cell Carcinoma (RCC) metastasizes in approximately 20–30% cases. The most common sites for 
metastases are the lungs, bones, liver, and brain. Metastases of RCC in the gastrointestinal tract (GIT) are very rare. 
Metastatic RCC has a poor prognosis. We herein present a case series of three patients with metastatic disease in the 
colon, duodenum, and pancreas following complete resection of RCC.
Methods: Hematoxylin and Eosin and immunohistochemical slides of 3 cases of RCC metastatic to GIT were 
reviewed. These cases were diagnosed between 2002 and 2019 at French Medical Institute for Mothers and Children 
(FMIC), Kabul, Afghanistan, and Aga Khan University Hospital (AKUH), Karachi, Pakistan. We also present a detailed 
review of published literature.
Results: We reviewed cases of three patients, two females and one male, with a mean age of 57.3 years (range 
40–67 years) who underwent nephrectomy for RCC. They developed metastases in the colon, pancreas, and duode‑
num, respectively 12–168 months (median time 156 months) following primary tumor resection. The patient with 
metastatic RCC in colon presented with abdominal pain and constipation. An ulcerated mass was found on colonos‑
copy 30 cm from the anal verge. Diagnosis of RCC with rhabdoid features was confirmed in both primary and meta‑
static tumors. The second patient developed a metastatic nodule in the head of pancreatic while the third patient 
developed metastatic nodules in the duodenum and pancreas which were detected by Computed Tomography (CT) 
scanning. Histopathological examination confirmed the presence of clear cell RCC in the metastatic nodules in both 
cases.
Conclusion: Metastatic RCC should be considered in the differential diagnosis of mass in the gastrointestinal 
(including pancreaticobiliary) tract especially in presence of a past history of RCC. These patients should be screened 
thoroughly by physical examination and appropriate imaging studies.
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Background
Renal cell carcinoma (RCC) accounts 85% of renal neo-
plasms and 2% of all malignant neoplasm of the body. 
Commonly RCC develops in the cortical region of the 
kidney. RCC is more common in males [1]. Among many 
different histologic variants of RCC, clear cell RCC is 
the most common histological type, around 75–80% of 
RCCs cases [2]. Papillary and chromophobe RCC types 
comprise approximately 10% and 5% of all RCC tumors, 
respectively. Papillary and chromophobe RCC are less 
aggressive while collecting duct carcinoma and unclas-
sified RCC are rarer and more aggressive [3]. RCC with 
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rhabdoid features generally are more aggressive with 
rapid growing and causing high mortality rate. Stud-
ies found that median survival rates ranged from 8 to 
31 months and metastasis occurs in up to 70% of rhab-
doid cases [4–6]. Overall, RCC metastasize in approxi-
mately 25% cases. Lungs, bones, liver and brain are the 
most frequent sites where RCCs are metastasizing. How-
ever, gastrointestinal tract (GIT) is not the common site 
of metastatic RCCs and rarely reported [7]. RCC has the 
potential to metastases to the distant organ after many 
years [8]. Metastatic RCC has poor prognosis with a 
5-year survival of 0–18% in patients with untreated met-
astatic disease [9]. Thomason et al. in 1991, reported the 
first case of RCC metastasizing to colon and based on our 
extensive literature review, to date 26 cases have been 
reported in literature [10–35] (Table 1).
We present three cases with colonic, duodenal and 
pancreatic metastases following complete resection of 
RCC of clear cell and rhabdoid types.
Methods
The Surgical Pathology files of Section of Histopathol-
ogy, Departments of Pathology and Clinical Labora-
tory, French Medical Institute for Mothers and Children 
(FMIC) and Aga Khan University Hospital (AKUH) were 
searched for cases of metastatic RCC reported between 
2002 and 2019. The histological slides were reviewed by 
two of the principal authors (JAG and NU). All Hematox-
ylin and Eosin (H&E) and immunohistochemical (IHC) 
stained slides of the primary and metastatic tumors were 
reviewed. Since this was a retrospective study involv-
ing review of H&E slides, chart review and analysis of 
radiological findings, ethical approval was not sought. 
Informed consent was obtained from patients in whom 
follow up was available.
Result
A total 3 cases were reported, one case at FMIC and two 
cases at AKUH.
Table 1 Reported cases of metastatic renal cell carcinoma in colorectum
* NM not mentioned
Number cases [citation] Age/sex Symptoms Site Interval Histology
1. Ruiz et al. [10] 73 Y/M Obstruction Transverse colon 11 years Clear cell
2. Thomason et al. [11] 71 Y/M Bowel changes habit Descending colon 17 years Clear cell
3. Zerbib et al. [12] 64 Y/M Bleeding Descending colon At time of diagnosis Clear cell
4. Tokonabe et al. [13] 83 Y/M Melena Transverse colon 7 years Clear cell
5. Avital et al. [14] 72 Y/F NM* Right colon 5 years Clear cell
6. Misu et al. [15] 67 Y/M Constipation Sigmoid colon 4 years Clear cell
7. Sawh et al. [16] 53 Y/M Pain and bleeding Anus 9 years Clear cell
8. Rosito et al. [17] 55 Y/M Hematochezia Distal rectum 9 months Clear cell
9. Mori et al. [18] 71 Y/M Fecal occult blood Ascending colon At time of diagnosis Clear cell
10. Dellon et al. [19] 70 Y/M Hematochezia Rectum NM NM
11. Víctor Edmundo et al. [20] 60 Y/M Hematochezia Splenic flexure 8 years Clear cell
12. Yetkin et al. [21] 60 Y/M Dyspepsia and pain Hepatic flexure 5 years Clear cell
13. Jadav et al. [22] 67 Y/F Abdominal pain Transverse colon 9 years Clear cell
14. Chetty [23] 92 Y/M Asymptomatic Ascending and sigmoid colon 17 years Clear cell
15. Zhao et al. [24] 54 Y/M Hematochezia Ascending colon At time of diagnosis Chromophobe
16. Milović et al. [25] 63 Y/M Bloating Sigmoid colon 10 Months NM
17. Tsamis et al. [26] 64 Y/M Anemia Ascending colon 5 Months NM
18. Davies et al. [27] 76 Y/M NM Perianal 7 years Clear cell
19. Elaine Vo et al. [28] 67 Y/M Hematochezia Rectosigmoid 9 years Clear cell
20. Yuji Maehata et al. 2016 [29] 61 Y/M hematochezia Rectum NM Clear cell
21. Berry et al. [30] 75 Y/M Abdominal pain Sigmoid colon At time of diagnosis Papillary
22. Guoyang Zheng et al. [31] 65 Y/M NM Rectum 10 years Clear cell
23. Simon Ouellet et al. [32] 78 Y/M Painless bleeding Rectum NM Clear cell
24. Valere et al. [33] 33 Y/F Abdominal pain Descending colon 3 years Sarcomatoid
25. Subaşı et al. [34] 63 Y/M hematochezia Splenic flexure 5 years Clear cell
26. Kataoka et al. [35] 65 Y/M Hip joint pain Ascending colon 1 year Clear cell
27. Current case 46 Y/F Pain and constipation Descending colon 1 year Rhabdoid RCC 
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Case 1 A 40-year-old woman with a history of per-
sistent abdominal pain and constipation along with 
bleeding per rectum was referred by her physician to a 
gastroenterologist at a private hospital. She had these 
symptoms for three months. A colonoscopy examina-
tion was performed and revealed an ulcerated growth at 
30 cm from the anal verge. A biopsy from the ulcerated 
mass was performed during the colonoscopy procedure 
and reported as hematoma. No dysplasia or malignancy 
were observed. Patient gave history of radical nephrec-
tomy one year ago performed at another private hos-
pital. The nephrectomy specimen was diagnosed on 
histopathological examination as urothelial carcinoma 
in a private pathology laboratory. Gastroenterologist was 
not satisfied with diagnosis and referred the patient to a 
surgeon at his hospital. The patient underwent segmental 
resection of the colon and specimen was sent to us for 
histopathological examination. The specimen consisted 
of a 54 cm segment of colon. On opening, an exophytic 
mass with nodular surface measuring 11 × 6 × 4  cm 
was seen in the distal portion of the segment (Fig.  1a). 
Representative sections from the mass were submitted 
for histopathological examination. On histopathologi-
cal examination, sheets of large pleomorphic neoplastic 
cells with large amount eosinophilic cytoplasm, enlarged, 
pleomorphic, hyperchromatic eccentric nuclei and vis-
ible nucleoli (rhabdoid pattern) were seen (Fig. 1b, c). In 
areas, tumors cells showed an alveolar arrangement. The 
classic histologic pattern of RCC was not observed. IHC 
stains were performed on neoplastic cells and showed 
positivity for cytokeratin (CK) AE1/AE3 and Cam 5.2, 
SATB2, vimentin and PAX8 (Fig.  1d). The tumor cells 
did not show reactivity with TFE3, desmin, MyoD1, 
S100 protein, anti-smooth muscle actin (ASMA), HMB-
45, Melan A, CK7, CK20, CDX2, CD34, CD117, synap-
tophysin, and Hepar-1. Based on above IHC staining 
profile a final diagnosis of RCC with rhabdoid features 
metastasizing to colon was rendered. Tissue slides of the 
previous nephrectomy specimen were also re-evaluated, 
and the microscopic findings concur with diagnosis of 
RCC with rhabdoid features. The pathological stage of 
radical nephrectomy was pT2aNxMx with tumor size 
of 7.5 cm in the greatest dimension. Patient died of dis-
ease 4 months after the diagnosis of colonic metastasis of 
RCC.
Case 2 A 67-year-old woman visited our hospital 
with complain of persistent abdominal pain. Her Com-
puted Tomography (CT) scan findings showed a mass 
Fig. 1 Grossly after opening of the segment of rectum, there was an exophytic mass with lobulated surface (a). On microscopic low power, a 
submucosal neoplasm arranged in sheets, alveolar and rhabdoid patterns was seen (b). The neoplastic cells were pleomorphic having abundant 
eosinophilic cytoplasm, enlarged hyperchromatic eccentric nuclei and prominent nucleoli (c). IHC stains were positive for PAX8 (d)
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in pancreatic head (Fig.  2a). Suspicion of a neuroendo-
crine tumor was raised. The patient had a history of right 
radical nephrectomy performed 14 years ago which was 
diagnosed as clear cell RCC, Fuhrman’s nuclear grade II 
and staged pT1bNxMx. The tumor measured 5.5 × 5 × 4 
cm. CT guided core needle biopsy of the pancreatic head 
mass was performed and sent to us for histopathologi-
cal examination. Grossly three linear cores were found. 
Microscopically, a neoplastic lesion was seen. Tumor cells 
were large with distinct cell borders, central round hyper-
chromatic nuclei, visible nucleoli and abundant clear 
cytoplasm (Fig.  2b). Special stain PAS ± D reveal abun-
dant cytoplasmic glycogen in the tumor cells. On IHC, 
tumor cells expressed RCC, PAX8, CD10 and Vimentin 
(Fig. 2c, d) and were negative for CK7 and CK20. Diag-
nosis of metastatic clear cell RCC was confirmed. Patient 
refused further treatment. Seven months later, she devel-
oped shortness of breath and her condition deteriorated. 
On admission, her chest x-ray showed pleural effusion 
and infiltrates in both lungs suggestive of metastatic dis-
ease. She died after a week.
Cases 3 A 65-year-old man with a history of right 
radical nephrectomy 11  years ago for a renal mass, was 
on regular follow up with CT scan abdomen. The renal 
mass was measured as 9.5 × 5 × 4cm and was diagnosed 
as clear cell RCC, Fuhrman’s nuclear grade II and staged 
pT2aNxMx. Recently, the follow up CT scan revealed 
single nodules in duodenum and pancreas. Metastatic 
disease was suspected, and Whipple’s resection was 
done, which consisted of part of stomach, duodenum, 
pancreas and gallbladder. Grossly, a mass measuring 
4 × 3.5 × 3.5  cm was found in duodenum while another 
mass measuring 3 × 2.5  cm was identified in the pan-
creas. Representative sections from both nodules were 
submitted for histopathological examination. Micro-
scopic examination of both nodules revealed a neoplas-
tic lesion arranged in nests and cords separated by thin 
vascular septae. The neoplastic cells were polygonal in 
shape with clear cytoplasm and rounded, hyperchromatic 
nuclei. The cells were diffusely positive for cytoplasmic 
glycogen highlighted on special stain PAS ± D. A panel 
of IHC stains was performed. The neoplastic cells were 
positive for CK AE1/AE3, CK Cam 5.2 and Vimentin 
and negative for Chromogranin A, Synaptophysin and 
S100. In view of clinical history, morphology and IHC 
profile, diagnosis of metastatic clear cell RCC was made. 
Patient died a week after surgery due to postoperative 
complications.
Fig. 2 CT scan findings reveals a mass in pancreatic head (a). Microscopically, the tumor cells were large and have distinct cell borders with central 
round hyperchromatic nuclei and abundant clear cytoplasm (b). IHC stains were positive for RCC (c) and PAX8 (d)
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Discussion
RCC is the most common type of renal neoplasms in 
patients above 50  years of age. It is more common in 
males with a male to female ratio of 2:1 [1]. In about 
20–30% cases, primary RCC and its metastasis to the 
distant organ will be diagnosed in the same time, which 
is called synchronous presentation. 20% of RCC patients 
with non-metastatic disease at diagnosis will later 
develop metastases during follow-up (metachronous 
presentation) [36].
In very rare cases of RCC, metastatic involvement of 
GI tract can be observed. Metastasize to any part of GI 
tract can occur but metastasis to colonic is much rarer 
compared to gastric and to small intestine [37]. Colon 
usually involved by metastatic cancers from breast, stom-
ach and malignant melanoma of the skin [38]. RCC not 
infrequently metastasizes to pancreas, RCC metastases 
to pancreas account for 2–5% of all pancreatic neoplasms 
and metastatic RCC is the most common secondary neo-
plasms in the pancreas followed by malignant melanoma 
and colorectal carcinoma [39]. Metastasis of RCC to per-
iampullary region is very rare and can occur several years 
(6.5–12) after resection of primary renal tumor. Metas-
tasis 32  years following previous resection has been 
reported [40]. In these patients overall, 5-year survival 
rates are less than 10% but surgical resection can improve 
5-year survival rates up to 88%. Improvement in survival 
is even seen in multi-focal metastasis [40]. A 5-year sur-
vival rate of 75% was reported in a retrospective study of 
surgically treated pancreatic metastases in ten patients, 
with the longest survivor at 117 months after resection. 
Therefore, the study suggests that RCC metastasis to 
pancreas should be managed aggressively with complete 
resection [41]. European Association of Urology (EAU) 
suggests that metastasectomy remained, by default, an 
appropriate local treatment for most sites with the excep-
tion of brain and possibly bone metastases, which are fre-
quently treated by stereotactic radiotherapy [42].
In our study, the time for metastases to pancreas fol-
lowing nephrectomy was 14 years in case 2 and 11 years 
in case 3.
A study reported two cases of metastatic RCC in the 
pancreas with mean time of metastasis of 41.5  months 
(0–108). Both patients were males aged 65 and 87 years 
[43]. RCC metastasis to colon can occur several years 
following curative resection of the primary tumor or 
it can occur soon after resection [44]. On reviewing 
the reported cases of colon-rectal metastasis of RCC 
(Table 1), one found that most colon metastases occurred 
after 5  years (maximum 17  years). Only three cases 
metastasized to colon within one year after resection of 
primary RCC. Interestingly, all reported cases of meta-
static RCC in colon occurred in males and all patients 
were over 50  years old (53–92  years), while in our case 
metastatic RCC to colon occurred in a female patient who 
was below 50 years of age (46 years). In addition, major-
ity of reported metastatic RCC cases in colon presented 
with rectal bleeding. Therefore, metastatic RCC should 
be kept in mind in patients with known history of RCC 
who presented with rectal bleeding. In our case, patients 
presented with abdominal pain and constipation, prob-
ably be due to large size of the mass (11× 66 × 64 cm).
In our study, metastasis to pancreas and pancreatico-
duodenal region occurred after 11 and 14  years after 
resection of primary RCC.
In terms of appearance, we found in published lit-
erature cases of metastatic RCC in pancreas have been 
mostly reported in men (75%) with average age of 
65.5 years [41]. Metastases can occur through lymphatic 
or hematogenous routes or by direct invasion. Large 
tumor size increases the chances of metastatic spread. 
However, metastases to lymph nodes and distant organs 
can occur even in the early stages of RCC [45].
On literature review, not surprisingly, the most com-
mon metastatic type of RCC to GI tract is clear cell type, 
the commonest RCC subtype [46]. However, papillary 
type, chromophobe type and sarcomatoid type RCC 
metastasizing to colon have been reported [37, 47, 48].
In our case, metastatic RCC in colon turned out to be 
RCC with rhabdoid features. Among subtypes of RCC 
the rhabdoid features is very rare account up to 5% of 
all RCCs. RCC having rhabdoid features behave more 
aggressively and usually develops extra renal invasion and 
has higher potential for distant organ metastases com-
paring to other subtypes of RCC. Therefore, the progno-
sis of patients diagnosed RCC with rhabdoid features is 
very poor [49].
Histologically, rhabdoid cells are characterized by large 
polygonal cells with large amount pink-eosinophilic cyto-
plasm and having pleomorphic eccentric nuclei with vis-
ible large nucleoli. On IHC staining, rhabdoid cells show 
positive reactivity with vimentin, epithelial membrane 
antigen (EMA), cytokeratins and PAX8 but not reactive 
for desmin, myoglobin, myogenin and Myo D1 [4, 50]. To 
the best of our knowledge no case of metastatic RCC with 
rhabdoid features has been reported in literature and our 
case represents the first case of RCC with rhabdoid fea-
tures metastasizing to colon. RCC with rhabdoid features 
should be differentiated from other malignant tumors 
having rhabdoid cell morphology. Alveolar Soft Part Sar-
coma (ASPS) has the similar histologic morphology, the 
cells are arranged in alveolar pattern and are polygonal 
with eosinophilic granular cytoplasm. ASPS can rarely 
occur or metastasize to colon. On IHC staining, Myo D1, 
TFE3 and vimentin widely expressed among ASPS cells 
[51], while these stains were not expressed in our case. 
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Another malignant neoplasm which has the similar mor-
phology is pleomorphic rhabdomyosarcoma. Pleomor-
phic rhabdomyosarcoma having large pleomorphic and 
polygonal cells of rhabdomyoblasts. On IHC staining, 
the neoplastic cells in pleomorphic rhabdomyosarcoma 
show positive reactivity with myogenin, desmin, smooth 
muscle actin (SMA) and vimentin. The cells of RCC with 
rhabdoid features do not express these markers [52].
It is quite difficult to distinguish metastatic RCC having 
rhabdoid features from ASPS and pleomorphic rhabdo-
myosarcoma only on histologic morphology. In our case, 
IHC profile helped to diagnose the RCC with rhabdoid 
features over ASPS and pleomorphic rhabdomyosar-
coma. Our case was negative for TFE3, Myo D1, myo-
genin, desmin and positive for renal cell markers such as 
PAX8 and Cam5.2. In addition, history of nephrectomy 
and review of previous nephrectomy slides further sup-
ported the diagnosis of metastatic RCC with rhabdoid 
features.
Metastasis to colon in the current study occurred in 
less than one year following nephrectomy. This interval 
is much shorter than in the literature. This is probably 
because RCC with rhabdoid features is an aggressive type 
of RCC with high potential for rapid early metastasis.
Few differential diagnoses should also be kept in mind 
RCC metastasizing to pancreas. These include solid vari-
ant of serous cystadenoma of pancreas whose cells may 
have clear cytoplasm and well-defined cell borders. How-
ever, hemorrhage and nuclear atypia are rare. In contrast, 
metastatic RCC usually demonstrates foci of hemor-
rhage and nuclear atypia. Expression of PAX8 and CD10 
by RCC cells is important for confirmation [53, 54]. It 
should also be kept in mind that cases of metastatic RCC 
to pancreas with underlying primary pancreatic micro-
cystic serous cystadenoma have been reported and may 
cause difficulty in identifying metastatic RCC [55]. In 
such cases, careful microscopic evaluation along with 
IHC staining can differentiate the two tumors as serous 
cystadenoma cells do not express CD10 and PAX-8 and 
RCC but are positive for CK7 while RCC cells are nega-
tive for CK7 and positive for CD10 and PAX-8. Solid 
pseudo-papillary neoplasm (SPN) of the pancreas with 
clear cell features is another entity that must be differen-
tiate from metastatic RCC. However, this tumor occurs 
mostly in young age and tumor cells are positive for syn-
aptophysin and B-catenin [56].
PEComa should be also considered in differential diag-
nosis, although, it rarely occurs in pancreas and colon 
but, the similar histologic morphology can be challenge-
able. PEComa has polygonal to round cells and are hav-
ing clear cytoplasm. To surely differentiate it from RCC 
with rhabdoid features, IHC staining is required. Tumor 
cells in PEComa strongly express ASMA and HMB45 
stains while these IHC stains are negative for RCC cells 
[57]. Radiology is of little significance in diagnosing skin 
metastasis. However, metastasis of RCC to other loca-
tions can be recognized [58].
Histology is the gold standard for diagnosing metas-
tasis and should be performed in all situations with ade-
quate precautions. Light microscopy alone cannot help 
much in differentiating metastatic RCC from other clear 
cell tumors and IHC is required for accurate diagnosis 
[59].
Conclusion
Metastatic RCC especially of clear cell subtype to the 
colon and pancreas should be considered in the differ-
ential diagnosis especially if there is a previous history of 
RCC or nephrectomy. Patients with lower GI symptoms 
or mass, particularly those patients with the past history 
of renal mass or nephrectomy should be screened thor-
oughly by physical examination and imaging modalities 
for metastases to gastrointestinal tract (including pancre-
aticobiliary tract) and other locations.
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